SCHEMBL7912137

SCHEMBL7912137

Cc1ccc(-c2nnc(Nc3ccccc3)c3cc(C)c(C)cc23)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 4/20 0.56
ENPP3 O14638 2/20 0.55
KDR P35968 2/20 0.55
TP53 P04637 6/20 0.55
THRB P10828 1/20 0.55
GPR174 Q9BXC1 1/20 0.54
ALDH1A1 P00352 2/20 0.52
MAPT P10636 6/20 0.51
GAA P10253 2/20 0.51
HPGD P15428 3/20 0.50
POLB P06746 1/20 0.50
HTT P42858 1/20 0.50
KMT2A Q03164 1/20 0.50
KDM4E B2RXH2 1/20 0.49
PDE5A O76074 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
ALOX15 P16050 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7912315 0.93 NPSR1 (0.56) NPSR1ENPP3KDRTP53THRB
SCHEMBL7913307 0.89 NPSR1 (0.53) NPSR1ENPP3KDRTP53THRB
SCHEMBL7904917 0.89 ENPP3 (0.57) NPSR1ENPP3KDRTP53THRB
SCHEMBL7905029 0.87 NPSR1 (0.73) NPSR1ENPP3KDRTP53THRB
SCHEMBL7914883 0.87 MAPT (0.62) NPSR1ENPP3KDRTP53THRB
SCHEMBL7915059 0.87 NPSR1 (0.52) NPSR1ENPP3KDRTP53THRB
SCHEMBL7912167 0.85 MAPT (0.63) NPSR1ENPP3KDRTP53THRB
SCHEMBL7905054 0.84 NPSR1 (0.57) NPSR1ENPP3KDRTP53THRB
SCHEMBL7913363 0.84 NPSR1 (0.57) NPSR1ENPP3KDRTP53THRB
SCHEMBL7904904 0.83 CA1 (0.50) NPSR1KDRTP53ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207666-B1 TREATING PRECANCEROUS LESIONS BY ADMINISTERING 4-PHENYLPHTHALAZINE DERIVATIVE CELL PATHWAYS, INC. 2001-03-27 US disclosed